Image pharmaphorum Editor Views & Analysis Coronavirus pharma news roundup - 07/08/20 Pharma’s reputation has soared due to the COVID-19 pandemic – but coronavirus is starting to bite companies’ sales. Views & Analysis Tackling multimorbidity through collaboration As populations age, multimorbidity becomes an increasingly pertinent issue for healthcare systems. Views & Analysis Preparing for an influx of cell and gene therapy approvals Cell and gene therapies offer some of the most groundbreaking advancements in patient care the pharma industry has ever seen. Views & Analysis Coronavirus pharma news roundup – 31/07/20 Vaccines, AI-driven drug discovery and llamas all hit the headlines this week as the search for a way to end the COVID-19 pandemic continues. Load more results
Views & Analysis Coronavirus pharma news roundup - 07/08/20 Pharma’s reputation has soared due to the COVID-19 pandemic – but coronavirus is starting to bite companies’ sales.
Views & Analysis Tackling multimorbidity through collaboration As populations age, multimorbidity becomes an increasingly pertinent issue for healthcare systems.
Views & Analysis Preparing for an influx of cell and gene therapy approvals Cell and gene therapies offer some of the most groundbreaking advancements in patient care the pharma industry has ever seen.
Views & Analysis Coronavirus pharma news roundup – 31/07/20 Vaccines, AI-driven drug discovery and llamas all hit the headlines this week as the search for a way to end the COVID-19 pandemic continues.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
